Search clinical trials for: vantictumab

Total 3 results

OncoMed Pharmaceuticals, Inc.

Completed

A Study of Vantictumab (OMP-18R5) in Combination With Docetaxel in Patients With Previously Treated NSCLC

Solid Tumors

United States
OncoMed Pharmaceuticals, Inc.

Completed

A Study of Vantictumab (OMP-18R5) in Combination With Paclitaxel in Locally Recurrent or Metastatic Breast Cancer

Metastatic Breast Cancer

United States
OncoMed Pharmaceuticals, Inc.

Completed

A Study of Vantictumab (OMP-18R5) in Combination With Nab-Paclitaxel and Gemcitabine in Previously Untreated Stage IV Pancreatic Cancer

Pancreatic Cancer | Stage IV Pancreatic Cancer

United States

3

Subscribe